$Finch Therapeutics (FNCH.US)$ Director SMISEK JEFFERY A sold 1,470 shares of Common Stocks on Nov 22, 2023 at an average price of $3.64 for a total value of $5,350.8.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.